Human epidermal growth factor receptor 2 (HER2), a member of the epidermal growth factor receptor (EGFR) family of tyrosine kinases, is overexpressed in 25–30% of human breast cancers (Slamon et al, 1987, 1989). This evidence concerns the gene ERBB2 and breast cancer.